About Kileken ole-MoiYoi
Kileken ole-MoiYoi joined Novartis in September 2011 as the Manager of Capacity Building with the Malaria Initiative. Prior to Novartis, he was a Case Writer with the Global Health Delivery Project at Harvard. He led health system research projects, wrote several case studies on malaria treatment and prevention, and founded the Malaria Treatment and Prevention Community on GHDonline.
He has also worked for TechnoServe, a Washington DC-based international agricultural development organization, as a volunteer business consultant in Nairobi, Kenya. Prior to Technoserve, he worked with Community Centered Conservation in the Comoros, integrating economic development with marine conservation activities. While double majoring at Brown University (BA Political Economy of Development, BA Human Biology), he wrote an honors thesis on integrating principles of sustainable economic development with the fight against malaria in sub-Saharan Africa, and co-founded EduVision, a Zurich-based e-learning organization that focused on incorporating innovative information communication technology with rural education in developing countries.
All contributions made by this author are his own and do not necessarily represent the views of his employer, Novartis.
Role(s) / Profession(s)
- Manager (Site/Facility, Program, Project)
Website: http://www.novartis.com/ Type: For-Profit Organization Country: Switzerland About: Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz. The global headquarters are located in Basel, Switzerland. The mission of Novartis is to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.
- [ARCHIVED] Adherence & Retention
- Endemic Non-Communicable Diseases
- Global Health Nursing & Midwifery
- Global Surgery & Anesthesia
- Health IT
- [ARCHIVED] HIV Prevention
- HIV Treatment & Prevention
- Malaria Treatment & Prevention
- MDR-TB Treatment & Prevention
- Strengthening Health Systems: The Role of NGOs - November 7-11 2011
- TB Infection Control
In response to the question regarding the fragility of progress as noted by the 2009/10 increase in malaria incidence in Zambia, Rwanda, or Sao Tomé and Principe, Ari mentioned the significance of “Strengthening health care delivery systems to effectively deploy integrated malaria prevention, diagnosis, and treatment strategies on an on-going ...
A recent update from the United Nations General Assembly (posted as a resource: http://www.un.org/ga/search/view_doc.asp?symbol=A/66/169) highlights the progress achieved in the fight against malaria, consolidating data from several recently published reports. Over the past 10 years, reinvigorated global efforts to reduce the burden of malaria have led to an increase in ...
Kileken ole-MoiYoi replied to "RDTs vs. Presumptive Treatment: Medical Science vs. Pragmatism/ Economics" in the Malaria Treatment & Prevention community.
Thank you to all who participated in this fantastic discussion on RDTs vs. Presumptive Treatment: Medical Science vs. Pragmatism/Economics. We have published a peer-reviewed discussion brief summarizing the discussion and referencing the relevant documents. The discussion brief is available online in the Malaria Treatment and Prevention Community. We invite your ...
Kileken ole-MoiYoi replied to "Rapid Diagnostic Tests for Malaria in an Endemic Area - Journal Watch" in the Malaria Treatment & Prevention community.
There seems to be mixed findings on the treatment of RDT-negative patients: in some countries, health workers prescribe ACTs anyway (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914063/, http://malariajournal.com/content/9/1/209), while in others they prescribe antibiotics or antipyretics (http://www.ajtmh.org/cgi/content/abstract/83/6/1238). Although in a clinic setting it is clear that a patient with a negative RDT or microscopy result must ...
Kileken ole-MoiYoi started a discussion "Injectable Treatments for Severe Malaria (original post by Vince Waite: 24 Oct 2010)". in the Malaria Treatment & Prevention community.
Recently I was in Ghana and their protocol for Cerebral Malaria treatment did not include the 20mg/kg loading dose for Quinine which I have always used. I understand there is some literature that states that there is not a clear benefit to the loading dose. What are others doing? Is ...
Kileken ole-MoiYoi recommended "Malaria RDT Expert Panel SESSION 2: RDTs and Health Care Provider Behavior" in the community.
Kileken ole-MoiYoi recommended "Malaria resurgence: a systematic review and assessment of its causes" in the community.
Kileken ole-MoiYoi recommended "Seasonal prevention of malaria in African children" in the community.
Kileken ole-MoiYoi recommended "Malaria RDT Expert Panel SESSION 3: Assessment, Procurement and Financing" in the community.
Kileken ole-MoiYoi recommended "Lessons learned from Zambia: Discuss with Dr. Phil Thuma" in the community.
Kileken ole-MoiYoi recommended "The effect of mobile phone text-message reminders on adherence to malaria treatment protocols" in the community.
Kileken ole-MoiYoi recommended "Malaria RDT Expert Panel SESSION 1: Interpreting the Test in Context" in the community.